Skip to main content
Clinical Trials/NCT02187549
NCT02187549
Unknown
Not Applicable

Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee

Fidia Farmaceutici s.p.a.21 sites in 1 country332 target enrollmentJune 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Knee Osteoarthritis
Sponsor
Fidia Farmaceutici s.p.a.
Enrollment
332
Locations
21
Primary Endpoint
Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Pain Sub-score
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to determine whether intra-articular hyaluronic acid provides symptomatic relief of osteoarthritis of the knee.

Registry
clinicaltrials.gov
Start Date
June 2014
End Date
March 2016
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Fidia Farmaceutici s.p.a.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Symptomatic osteoarthritis of the knee.

Exclusion Criteria

  • No disorders which could interfere with study required assessments.

Outcomes

Primary Outcomes

Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Pain Sub-score

Time Frame: 26 weeks

Secondary Outcomes

  • Patient Global Assessment(26 weeks)

Study Sites (21)

Loading locations...

Similar Trials